Who Paid My Doc
Thomas Uncini
Anatomic Pathology Hibbing, MN
NPI 1710078654 CMS profile 924436
750 E 34Th St, Hibbing, MN 55746
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Thomas Uncini of Hibbing, MN.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$3,394
Medicare patients
60
Services billed
120
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 42% | |
| Diabetes | 37% | |
| Chronic kidney disease | 33% | |
| Ischemic heart disease | 32% | |
| Depression | 28% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Other Anatomic Pathology in Minnesota
Related records
Anatomic Pathology in Minnesota
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Minnesota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.